Considering the importance of ACE2 in cardiovascular (patho)physiology, it has been suggested that the loss of ACE2 catalytic function and dysregulation of the RAS may be responsible for the cardiovascular symptoms reported in COVID-19 patients [181–183,186]. This evidence concerns the gene ACE2 and COVID-19.